4Schalkwijk CG,Poland DC,van DW,et al.Plasma concentration of C-reactive protein is increased in type 1diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction:evidence for chronic inflammation.Diabetologia,1999,42:351-357.
5Romano M,Pomilio M,Vigneri S,et al.Endothelial perturbation in children and adolescents with type 1diabetes:association with markers of the inflammatory reaction.Diabetes Care,2001,24:1674-1678.
6Olimpia O,Isabel R,Paloma G,et al.Significance of high C-reactive protein levels in pre-dialysis patients.European Renal Association-European Dialysis and Transplant Association,2002.
7Korevaar JC,van Manen JG,Dekker FW,et al.Effect of an increase in C-reactive protein level during a hemodialysis session on mortality.J Am Soc Nephrol,2004,15(11):1916-1922.
8Stenvinkel P,Heimburgero,Paultre F,et al.Strong association between malnutrition,inflammation and atherosclerosis in chronic renal failure.Kidney Int,1999,55:1899-1911.
9Ahmet A,Kiykim J,Ahmet C,et al.Increased incidence of carotid artery wall change and associated variables in hemodialysis patients without symptomatic cardiovascular disease.Yonsei Med J,2004,45(2):247-154.
10Henglian W,Hongchu L.Implication of C-reactive protein in diabetic nephropathy.J Clin Nephrol,2004,4(3):117-119.
二级参考文献17
1Panichi V, Migliori M, Pieto DE, et al. Plasma C-reactive protein in hemodialysis patients: a cross-sectional, longitudinal clinical survey. Blood Purif. 2000,18 : 30-36.
2Stenvinkel P. Malnutrition and chronic inflammation as risk factors for cardiovascular disease in chronic renal failure. Blood Purif.2001,19: 143-151.
3Heimburger O, Qureshi AR, Blaner WS, et al. Hand-grip muscle strength, lean body mass, and plasma proteins as markers ofnutritional status in patients with chronic renal failure close to start ofdialysis therapy. Am J Kidney Dis. 2000 ,36:1213-1225.
4Bergstrom J, Lindholm B, Lacson E Jr,et al.What are the causes and consequences of the chronic inflammatory state in chronic dialysis patients?Semin Dial,2000,13:163-175.
5Arici M, Walls J.End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link?Kidney Int,2001,59:407-414.
6Hou FF, Miyata T, Boyce J,et al.beta(2)-Microglobulin modified with advanced glycation end products delays monocyte apoptosis.Kidney Int,2001,59:990-1002.
7Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease.Am J Kidney Dis,1998,32(5 Suppl 3):S112-S119.
8Kaysen GA. C-reactive protein: a story half told.Semin Dial,2000,13:143-146.
9Craven TE, Ryu JE, Espeland MA, et al.Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis. A case-control study.Circulation,1990,82:1230-1242.
10Moustapha A, Naso A, Nahlawi M,et al.Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease.Circulation,1998,97:138-141.
